http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2626073-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c6f221852967f10da91551d2c8e7a22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_270854205211430cfd1dfa8d517a41f8 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 |
filingDate | 2012-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d1667c978adbe89b1016d25b26c595f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7333ede23f22a110c43a2ed9ea482a44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c5b22640b932ed18152beb928f3873d8 |
publicationDate | 2013-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-2626073-A1 |
titleOfInvention | Compound for use in the prevention and/or treatment of a neurogenerative disease or a disease involving an activation of phosphodiesterase-4 (PDE4) |
abstract | The present invention relates to a compound for use in the prevention and/or treatment of a disease selected from a neurodegenerative disease, especially Alzheimer disease, and a disease involving an activation of phosphodiesterase-4 (PDE4), wherein said compound is of general formula (I) or a pharmaceutically acceptable salt or solvate thereof:n nwherein X and Z each independently represent CH or N; nY represents O or S; nR1, R2 and R3 may be the same or different and represent a hydrogen atom, a halogen atom, hydroxyl, nitro, cyano, amino, amido, carbamate, alkyl, alkenyl, alkynyl, alkoxy, heterocyclic, carbocyclic, alkylthio, carboxy, or alkoxycarbonyl; R4 represent a hydrogen atom; R5, R6, R7 and R8 may be the same or different and represent a hydrogen atom, halogen atom, hydroxyl, nitro, amino, alkyl, alkoxy, alkylthio, or trifluoromethyl; R9 and R10 may be the same or different and represent a hydrogen atom, alkyl, alkylcarbonyl, heterocyclic, carbocyclic, ONO 2 , or OSO 2 R wherein R is hydroxyl, alkyl, carbocyclic; and R11 represents an alkyl, alkenyl, alkynyl, alkoxy, akoxycarbonyl, amino, amido, heterocyclic, carbocyclic, or optionally substituted azolyl. |
priorityDate | 2012-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 236.